396 related articles for article (PubMed ID: 23834152)
1. Regulating miRNA by natural agents as a new strategy for cancer treatment.
Sethi S; Li Y; Sarkar FH
Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
3. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH
Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200
[TBL] [Abstract][Full Text] [Related]
4. Regulation of microRNAs by natural agents: new strategies in cancer therapies.
Phuah NH; Nagoor NH
Biomed Res Int; 2014; 2014():804510. PubMed ID: 25254214
[TBL] [Abstract][Full Text] [Related]
5. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
6. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
Li Y; Kong D; Wang Z; Sarkar FH
Pharm Res; 2010 Jun; 27(6):1027-41. PubMed ID: 20306121
[TBL] [Abstract][Full Text] [Related]
7. Cellular signaling perturbation by natural products.
Sarkar FH; Li Y; Wang Z; Kong D
Cell Signal; 2009 Nov; 21(11):1541-7. PubMed ID: 19298854
[TBL] [Abstract][Full Text] [Related]
8. Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer.
Pandima Devi K; Rajavel T; Daglia M; Nabavi SF; Bishayee A; Nabavi SM
Semin Cancer Biol; 2017 Oct; 46():146-157. PubMed ID: 28185862
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
10. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
11. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
12. Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.
Li Y; Wicha MS; Schwartz SJ; Sun D
J Nutr Biochem; 2011 Sep; 22(9):799-806. PubMed ID: 21295962
[TBL] [Abstract][Full Text] [Related]
13. The "Big Five" Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein.
Naujokat C; McKee DL
Curr Med Chem; 2021; 28(22):4321-4342. PubMed ID: 32107991
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
[TBL] [Abstract][Full Text] [Related]
15. Targeting miRNAs by natural products: A new way for cancer therapy.
Zhang B; Tian L; Xie J; Chen G; Wang F
Biomed Pharmacother; 2020 Oct; 130():110546. PubMed ID: 32721631
[TBL] [Abstract][Full Text] [Related]
16. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
17. Implication of microRNAs in drug resistance for designing novel cancer therapy.
Sarkar FH; Li Y; Wang Z; Kong D; Ali S
Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
19. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
